Diagnosis of Tuberculosis and Mycobacteriosis—Focus on Extrapulmonary Forms

A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Bacterial Pathogens".

Deadline for manuscript submissions: closed (31 December 2025) | Viewed by 892

Special Issue Editor


E-Mail Website
Guest Editor
One Health Research Group, Universidad de Las Américas, Quito 170530, Ecuador
Interests: tuberculosis diagnosis; molecular epidemiology and nontuberculous mycobacteria; hansen disease; leprosy

Special Issue Information

Dear Colleagues,

Tuberculosis and other mycobacterioses continue to pose a global health burden, with extrapulmonary tuberculosis (EPTB) representing 15–20% of all TB cases. 

EPTB presents unique diagnostic challenges due to its diverse clinical manifestations, nonspecific symptoms, and the limitations of conventional diagnostic methods. 

Unlike pulmonary TB, diagnosing EPTB often requires invasive sampling, specialized imaging, and advanced microbiological or molecular techniques—factors that contribute to delays in diagnosis and treatment, especially in resource-limited settings.

This Special Issue will spotlight the evolving landscape of diagnostics for TB and mycobacterioses, with a particular emphasis on extrapulmonary forms. 

We invite submissions exploring innovative strategies to overcome diagnostic barriers, including nucleic acid amplification tests (e.g., Xpert MTB/RIF Ultra), metagenomic next-generation sequencing (mNGS), and biomarker-based assays such as adenosine deaminase and interferon-gamma. Imaging tools such as PET-CT and MRI are increasingly vital for localizing occult infections, and artificial intelligence (AI) shows promise in enhancing image interpretation and diagnostic accuracy.

In addition to technical advances, we encourage contributions that address the clinical consequences of delayed diagnosis, such as increased morbidity and drug resistance, and the urgent need for accessible, point-of-care solutions. 

This Special Issue welcomes original research, systematic reviews, case reports, and implementation studies focusing on molecular diagnostics, imaging innovations, biomarker discovery, AI applications, and practical challenges in diagnosis.

By bringing together recent advances and expert insights, this Special Issue encourages collaboration between clinicians, researchers, and public health professionals to improve diagnostics, patient care, and health outcomes.

Dr. Jacobus H. de Waard
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • molecular diagnostics
  • imaging innovations
  • biomarker discovery
  • AI applications

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

11 pages, 750 KB  
Article
Patterns of Multidrug Resistance and Treatment Outcomes Among Pulmonary Tuberculosis Patients in Bangladesh
by Naima Nur, Azaz Bin Sharif, Anish Khan, Md Rashedul Islam, Hafid Soualhine, Zubaida Nasreen, Ahmadul Hasan Khan, Pronab Kumar Modak, Mohammad Faridul Alam, Safa Islam, Saeema Islam, Nisha Khan and Meenu Kaushal Sharma
Pathogens 2026, 15(2), 208; https://doi.org/10.3390/pathogens15020208 - 12 Feb 2026
Viewed by 634
Abstract
Background: To effectively manage tuberculosis (TB), it is essential to address the high incidence of the disease, as multidrug-resistant pulmonary TB (MDR-PTB) remains a significant concern to halt pre-extensive drug-resistant (pre-XDR) recrudescence. The objective of the current study was to examine and compare [...] Read more.
Background: To effectively manage tuberculosis (TB), it is essential to address the high incidence of the disease, as multidrug-resistant pulmonary TB (MDR-PTB) remains a significant concern to halt pre-extensive drug-resistant (pre-XDR) recrudescence. The objective of the current study was to examine and compare MDR-PTB patterns among adult PTB patients (>12 years) in Bangladesh’s urban and rural areas who had newly diagnosed and previously treated PTB. Methods: A total of 430 newly diagnosed and previously treated adult patients with PTB were randomly recruited during two study periods: the 1st period, from May 2010 to December 2010 (eight months), and the 2nd period, from January 2014 to January 2015 (thirteen months). Only the drug-resistant (DR) patients were included in the final analysis. Mycobacteriological tests, i.e., smear microscopy, culture, drug susceptibility testing (proportion method of Canetti), line-probe assay, and GeneXpert MTB/RIF were performed. Logistic regression analysis was used to determine the strength of associations between treatment outcomes and predictor variables. Results: Of the newly diagnosed patients, 156 cases were negative and drug-sensitive (DS) at diagnosis, and 274 patients exhibited various DR patterns. During the 1st period, MDR-PTB was 26% among newly diagnosed patients, while the proportion was 31% among previously treated patients in the 2nd period. The majority of MDR-PTB belonged to the age group of ≤45 years. Male patients consistently revealed a higher proportion of MDR-PTB compared to females in both the newly diagnosed and previously treated groups. Conclusion: The proportion of MDR-PTB was higher among the previously treated patients than among newly diagnosed patients. Regardless of demographic characteristics, a significant proportion of patients showed DR, particularly in previously treated groups, indicating a substantial burden of MDR-PTB. Full article
Show Figures

Figure 1

Back to TopTop